Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG.
Glutsch V, Schummer P, Kneitz H, Gesierich A, Goebeler M, Klein D, Posch C, Gebhardt C, Haferkamp S, Zimmer L, Becker JC, Leiter U, Weichenthal M, Schadendorf D, Ugurel S, Schilling B.
Glutsch V, et al. Among authors: goebeler m.
J Immunother Cancer. 2022 Nov;10(11):e005930. doi: 10.1136/jitc-2022-005930.
J Immunother Cancer. 2022.
PMID: 36450381
Free PMC article.